Silex Systems (SLX) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
31 Mar, 2026Executive summary
Achieved significant progress in commercialising SILEX laser-based uranium enrichment technology, with large-scale pilot demonstration (TRL-6) underway at GLE's Wilmington, NC facility and expected to complete by end of 2025, subject to independent assessment.
GLE acquired a 700-acre site in Paducah, KY for the planned Paducah Laser Enrichment Facility (PLEF), securing access to DOE's depleted uranium tails for up to 30 years of feedstock.
GLE selected as one of six awardees under the US DOE's LEU Enrichment Acquisition program, with initial $0.5m awarded and potential to bid for up to $900m in further funding.
Construction of the first full-scale Quantum Silicon (Q-Si) production plant module advanced, targeting the emerging quantum computing market.
Completed $130m institutional placement in August 2025 to support US commercialisation, isotope enrichment opportunities, and working capital.
Financial highlights
Revenue from continuing operations was $12.2m, down from $12.9m in the prior year, mainly due to lower interest revenue.
Net loss increased to $42.6m from $22.7m, primarily due to a $18.5m increase in Silex's 51% share of GLE's loss, reflecting higher GLE operating expenditures.
Other income rose to $6.4m, driven by higher R&D tax incentives and government grants.
Net assets at 30 June 2025 were $90.9m, down 31% from the prior year, with cash holdings of $80.6m and no corporate debt.
Earnings per share was a loss of 17.9 cents, compared to a loss of 9.6 cents in the prior year.
Outlook and guidance
GLE aims to complete TRL-6 pilot demonstration by end of 2025, with commercial operations at PLEF targeted no later than 2030, subject to successful validation, regulatory approval, and market conditions.
Ongoing focus on expanding SILEX technology applications in uranium enrichment, quantum silicon, and medical isotopes.
Potential for significant US government funding and industry partnerships to support commercialisation.
Latest events from Silex Systems
- GLE's SILEX technology targets US nuclear fuel independence with strong market and policy tailwinds.SLX
Investor presentation24 Feb 2026 - Revenue doubled and cash surged after a capital raise; GLE secured a major U.S. DOE award.SLX
H1 202624 Feb 2026 - Nuclear and quantum projects advanced, with strong cash reserves and key risks addressed.SLX
AGM 20243 Feb 2026 - Robust financials and tech milestones drive strategic growth in nuclear and silicon sectors.SLX
AGM 20253 Feb 2026 - Major technology milestone and US support position SILEX for uranium and quantum silicon growth.SLX
Investor Presentation9 Nov 2025 - $145m equity raise funds SILEX laser enrichment commercialisation, targeting US nuclear fuel supply.SLX
Investor Presentation7 Aug 2025 - GLE's SILEX technology is on track for commercialisation, targeting major US nuclear fuel supply gaps.SLX
Investor Presentation30 Jun 2025 - GLE pilot and Silex's diversification position the company for growth amid nuclear market shifts.SLX
H2 202413 Jun 2025 - GLE accelerates SILEX technology for uranium, silicon, and isotope markets, targeting 2028 launch.SLX
Investor Presentation13 Jun 2025